** Shares of Biome Australia BIO.AX rise as much as 20.3%
to A$0.385, their highest level since May 29
** Stock on track for its best day since May 28, if gains
hold
** Health co expects to exceed its upgraded revenue forecast
of A$12.5 mln ($8.26 mln) for FY24
** BIO posted unaudited sales revenue of A$7.23 mln in FY23
** Co sees second consecutive quarter of positive underlying
operating cashflow and EBITDA in Q4
** Says forecast due to strong sell-through numbers in
pharmacy and practitioner channels
** More than 570,000 shares change hand, compared to 30-day
average trading volume of 266,775 shares
** Stock up more than 50% YTD, as of last close
($1 = 1.5135 Australian dollars)
(Reporting by John Biju in Bengaluru)
((John.Biju@thomsonreuters.com;))